Company : Company news » Press Releases

GenScript sponsors 2011 iGEM undergraduate Synthetic Biology competition

Piscataway, NJ Dec 2011 — Internationally recognized biotech company GenScript congratulates the achievements of eight teams we sponsored in 2011 iGEM undergraduate synthetic biology competition.

The iGEM teams have utilized GenScript's gene synthesis service to build novel biological systems. After intense preliminary regional competitions, three teams made to the final competition on Nov. 7th, the 1st ever iGEM World Championship Jamboree held on MIT campus in Cambridge, MA. Their projects include painting using engineered bacteria expressing light inducible fluorescent proteins, creating neuro-stimulators by building an OptoMagneto bacteria, and designing a set of Codon-Switches that regulate target protein biosynthesis. To learn more about these iGEM projects, please visit: http://www.genscript.com/events_1.html

The rapidly expanding science of synthetic biology is a field GenScript, the leading synthetic biology company in the world and the No. 1 gene synthesis supplier in North America, has helped pioneer since 2002. The science involves reducing the complexity of life down to basic building blocks of molecular biology, which can then be mixed and matched to create useful organisms in biofuel production, industrial biotechnology development, and ultimately, to promote human health.

About GenScript
GenScript is the leading gene, peptide, protein and antibody research partner for fundamental life science research, translational biomedical research, and early stage pharmaceutical development. Since our establishment in 2002, GenScript has exponentially grown to become a global leading biotech company that provides life sciences services and products to scientists over 100 countries worldwide. During our tenure we have built the best-in-class capacity and capability for biological research services encompassing gene synthesis and molecular biology, peptide synthesis, custom antibodies, protein expression, antibody and protein engineering, and in vitro and in vivo pharmacology – all with the goal to Make Research Easy.

About iGEM.
Since its inception in 2003 from a short course at MIT, the International Genetically Engineered Machine competition (iGEM) has become the premiere undergraduate Synthetic Biology competition, an international sensation, and a significant force to the advancement of synthetic biology. 165 teams from 29 countries and regions have participated in 2011 iGEM to dive into the synthetic biology area. igem.org/Main_Page

# # # #

For further information, please contact:
Sally Wang
Executive Vice President
GenScript
[email protected]
1-(732) 885-9188

Source: http://www.genscript.com

Your Innovation Partner in Drug Discovery!